Search Results - "Myrthue, Anne"

  • Showing 1 - 13 results of 13
Refine Results
  1. 1

    Calcitriol in cancer treatment: from the lab to the clinic by Beer, Tomasz M, Myrthue, Anne

    Published in Molecular cancer therapeutics (01-03-2004)
    “…1,25-Dihydroxyvitamin D (calcitriol), the most active metabolite of vitamin D, has significant antineoplastic activity in preclinical models. Several…”
    Get full text
    Journal Article
  2. 2

    CCL2 is induced by chemotherapy and protects prostate cancer cells from docetaxel-induced cytotoxicity by Qian, David Z., Rademacher, Brooks L.S., Pittsenbarger, Janet, Huang, Chung-Ying, Myrthue, Anne, Higano, Celestia S., Garzotto, Mark, Nelson, Peter S., Beer, Tomasz M.

    Published in The Prostate (01-03-2010)
    “…BACKGROUND Metastatic prostate cancer is either inherently resistant to chemotherapy or rapidly acquires this phenotype after chemotherapy exposure. In this…”
    Get full text
    Journal Article
  3. 3

    Calcitriol in the Treatment of Prostate Cancer by BEER, Tomasz M, MYRTHUE, Anne

    Published in Anticancer research (01-07-2006)
    “…Calcitriol, the principal active metabolite of vitamin D and a naturally occurring hormone, showed significant antineoplastic activity in pre-clinical models…”
    Get full text
    Journal Article Conference Proceeding
  4. 4

    ID1 enhances docetaxel cytotoxicity in prostate cancer cells through inhibition of p21 by Geng, Hao, Rademacher, Brooks L, Pittsenbarger, Janet, Huang, Chung-Ying, Harvey, Christopher T, Lafortune, Marie C, Myrthue, Anne, Garzotto, Mark, Nelson, Peter S, Beer, Tomasz M, Qian, David Z

    Published in Cancer research (Chicago, Ill.) (15-04-2010)
    “…To identify potential mechanisms underlying prostate cancer chemotherapy response and resistance, we compared the gene expression profiles in high-risk human…”
    Get full text
    Journal Article
  5. 5

    Randomized Study of High-Dose Pulse Calcitriol or Placebo prior to Radical Prostatectomy by Beer, Tomasz M, Myrthue, Anne, Garzotto, Mark, O'hara, Michael F, Chin, Raymond, Lowe, Bruce A, Montalto, Michelle A, Corless, Christopher L, Henner, W David

    “…Background: Cancer chemoprevention trials require enormous resources due to the large numbers of patients and the years of follow-up needed to achieve…”
    Get full text
    Journal Article
  6. 6

    Effect of Calcitriol on Prostate-Specific Antigen In vitro and in Humans by BEER, Tomasz M, GARZOTTO, Mark, PARK, Byung, MORI, Motomi, MYRTHUE, Anne, JANEBA, Nicole, SAUER, David, EILERS, Kristine

    Published in Clinical cancer research (01-05-2006)
    “…Background: Calcitriol, the natural ligand for the vitamin D receptor, has significant potential in prostate cancer treatment. Measurement of its…”
    Get full text
    Journal Article
  7. 7

    The Iroquois Homeobox Gene 5 Is Regulated by 1,25-Dihydroxyvitamin D3 in Human Prostate Cancer and Regulates Apoptosis and the Cell Cycle in LNCaP Prostate Cancer Cells by MYRTHUE, Anne, RADEMACHER, Brooks L. S, PITTSENBARGER, Janet, KUTYBA-BROOKS, Bozena, GANTNER, Marin, QIAN, David Z, BEER, Tomasz M

    Published in Clinical cancer research (01-06-2008)
    “…1,25-Dihydroxyvitamin D 3 [1,25(OH) 2 D 3 ], the most active metabolite of vitamin D 3 , has significant antitumor activity in a broad range of preclinical…”
    Get full text
    Journal Article
  8. 8

    Rationale for the development and current status of calcitriol in androgen-independent prostate cancer by BEER, Tomasz M, MYRTHUE, Anne, EILERS, Kristine M

    Published in World journal of urology (01-02-2005)
    “…Calcitriol, the principal active metabolite of vitamin D, has significant antineoplastic activity in pre-clinical models of prostate cancer and many other…”
    Get full text
    Journal Article
  9. 9

    ID1 enhances docetaxel cytotoxicity in prostate cancer cells via inhibition of p21 by Geng, Hao, Rademacher, Brooks L., Pittsenbarger, Janet, Huang, Chung-Ying, Harvey, Christopher T., Lafortune, Marie C., Myrthue, Anne, Garzotto, Mark, Nelson, Peter S., Beer, Tomasz M., Qian, David Z.

    Published in Cancer research (Chicago, Ill.) (13-04-2010)
    “…To identify potential mechanisms underlying prostate cancer chemotherapy response and resistance, we compared the gene expression profiles in high-risk human…”
    Get full text
    Journal Article
  10. 10

    The Iroquois Homeobox Gene 5 Is Regulated by 1,25-Dihydroxyvitamin D sub(3) in Human Prostate Cancer and Regulates Apoptosis and the Cell Cycle in LNCaP Prostate Cancer Cells by Myrthue, Anne, Rademacher, Brooks LS, Pittsenbarger, Janet, Kutyba-Brooks, Bozena, Gantner, Marin, Qian, David Z, Beer, Tomasz M

    Published in Clinical cancer research (01-06-2008)
    “…1,25-Dihydroxyvitamin D sub(3) [1,25(OH) sub(2)D sub(3)], the most active metabolite of vitamin D sub(3), has significant antitumor activity in a broad range…”
    Get full text
    Journal Article
  11. 11

    Neoadjuvant mitoxantrone and docetaxel for high-risk localized prostate cancer by Garzotto, Mark, Myrthue, Anne, Higano, Celestia S., Beer, Tomasz M.

    Published in Urologic oncology (01-05-2006)
    “…Currently available treatment modalities for high-risk clinically localized prostate cancer have limited chances of achieving complete tumor elimination…”
    Get full text
    Journal Article
  12. 12
  13. 13

    Characterization and partial purification of the MED -1 binding complexes by Myrthue, Anne

    Published 01-01-2000
    “…The hamster P-glycoprotein gene, pgp1, is the structural and functional homologue of the human MDR1 gene, which is associated with multidrug resistance in both…”
    Get full text
    Dissertation